With Musk’s X banned in Brazil, its users carve out new digital homes
Brazil’s social masses are primarily on TikTok, Instagram and Facebook, but X had outsize influence in terms of newsmakers, agenda setting and thought leaders.
Friday’s jobs report for August is going to be huge. Here’s what to expect
The Wall Street consensus is for nonfarm payrolls growth of 161,000 for August and a slight decline in the unemployment rate to 4.2%.
JPMorgan top economist says the Fed should cut rates by a half point this month
JPMorgan chief U.S. economist Michael Feroli believes there is a strong case for the Federal Reserve to speed up the pace of rate cuts.
CNBC’s Inside India newsletter: Stocks had a record-breaking rally. What’s next?
After a record-breaking 14-day rally, analyst fear risks are rising from the stock market’s own success.
OPEC+ members delay plans to hike production by two months after oil price slump
The increases were part of a plan to gradually return a broader 2.2 million barrels per day of supply to the market over the following months.
Ticketmaster’s pricing for Oasis tickets is under investigation in the UK
The U.K.’s competition watchdog has launched an investigation into the way tickets were sold for next year’s reunion concerts from iconic Britpop band Oasis.
Honor steps up challenge to Samsung with launch of thin foldable phone
Honor is ramping up its challenge to Samsung in the fast-growing foldable smartphone market.
Volvo Cars cuts margin and revenue aims after ditching 2030 electric vehicle target
The Swedish automaker is trimming its earnings margin goal for 2026 due to “increased complexity especially in relation to global trade and tariffs.”
Dow falls 200 points, S&P 500 posts third straight loss as growth fears plague investors: Live updates
Stocks struggled Thursday as investors dumped risk assets and concerns mounted over the outlook for the U.S. economy.
AstraZeneca says staff detained in China amid reports of a drug-import investigation
Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the company confirmed Thursday.
